Asset information about Galderma Group AG (GDERF)
Stock | ISIN: CH1335392721 | WKN: A407X6
Key Statistics
About Galderma Group AG
Galderma Group AG is a global dermatology company specializing in research, development, and marketing of innovative medical solutions in skin health. The company offers a wide range of products to treat a variety of skin conditions, including acne, rosacea, psoriasis, and skin cancer. Galderma's portfolio includes both prescription medications and over-the-counter skincare products. The company is committed to improving skin health and providing solutions for both patients and healthcare professionals around the world.
What many investors track for Galderma Group AG
- Catch strong price moves faster (e.g., with a multi-day delta alert).
- Track trend zones: distance to the 50/200-day moving average can act as a simple “radar”.
- Watch 52-week highs/lows for momentum or risk shifts.
- Use strategy notes so alert emails instantly remind you why you track this asset.
Note: This is not investment advice—just common tracking angles for organizing your watchlist.
FAQ: Alerts & strategy
How do I set an alert for this asset?
Sign in, add the asset to your watchlist, then create price or trend alerts. Wavealert notifies you by email when your conditions are met.
What is the 200-day moving average?
The 200-day moving average is a long-term trend indicator. Many use it to spot trend shifts or stability—and set alerts around it. Learn more about the 200-day line
What is a delta alert?
A delta alert doesn’t watch a single target price; it monitors the strongest positive/negative move within a time window—useful for spotting volatility quickly. Delta alert explained
More features: Price alerts · Notes · News analysis
Track this asset in your portfolio
Create alerts, track performance, and get notified about price movements.
Why Wavealert?
Get notified when prices reach your targets or move significantly.
Track 50/200 day moving averages and identify trends.
See what alerts other investors are watching.